58 results
424B3
PRE
Prenetics Global Limited - Ordinary Shares
16 Feb 24
Prospectus supplement
6:13am
and registration with the Medical Device Division of the Department of Health of Hong Kong in the Medical Device Administrative Control System, for which
F-3
PRE
Prenetics Global Limited - Ordinary Shares
17 Jan 24
Shelf registration (foreign)
6:59am
of the Department of Health of Hong Kong in the Medical Device Administrative Control System, for which the applicant must demonstrate the safety
F-3
EX-10.25
PRE
Prenetics Global Limited - Ordinary Shares
17 Jan 24
Shelf registration (foreign)
6:59am
-governmental, public or statutory authority of any nature (including any governmental division, department, agency, regulatory or administrative authority
6-K
PRE
Prenetics Global Limited - Ordinary Shares
30 Nov 23
Current report (foreign)
6:08am
Department of the Nasdaq Stock Market LLC (“Nasdaq”), dated November 29, 2023, indicating that the Company has regained compliance with the minimum bid
424B3
PRE
Prenetics Global Limited - Ordinary Shares
2 Nov 23
Prospectus supplement
4:04pm
728 King’s Road, Hong Kong
Tel: 852-2210 9588
Attention: Investor Relations Department
FORWARD-LOOKING STATEMENTS
This prospectus and any prospectus … , medical device manufacturers may voluntarily complete an application and registration with the Medical Device Division of the Department of Health
POS AM
df4bv 496paea4
6 Oct 23
Prospectus update (post-effective amendment)
1:52pm
F-3
7agxyr8
29 Sep 23
Shelf registration (foreign)
9:17am
424B3
1dxgaq
21 Jul 23
Prospectus supplement
6:16am
POS AM
d9zkyq pekrr9a
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
POS AM
EX-10.24
dhw7zioha b1r
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
POS AM
EX-10.23
9d4ddmuwyt1f
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
POS AM
3krlop 80m9k4oe
31 May 23
Prospectus update (post-effective amendment)
8:25am
POS AM
br2069sv2p3r3pbw6
1 May 23
Prospectus update (post-effective amendment)
5:19pm
6-K/A
EX-99.1
vf69ry9 yq
1 May 23
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
4:03pm
6-K
EX-99.1
og98ueyuuqasgqi
16 Dec 22
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
8:06am
POS AM
fayu7 t7jifz4hnjgk6e
14 Dec 22
Prospectus update (post-effective amendment)
8:04am
424B3
vsuf7v8srijruz031
1 Jul 22
Prospectus supplement
4:10pm